Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

WHEATON® Highlights Products at AACC 2014

Published: Thursday, July 24, 2014
Last Updated: Thursday, July 24, 2014
Bookmark and Share
The products to be featured at the meeting offer unique solutions for the clinical market.

WHEATON® today highlighted products to be featured at the 2014 AACC Annual Meeting that provide unique solutions addressing the specific needs of clinical laboratory and other clinical life sciences customers. These products showcase the company’s ongoing commitment to provide a range of distinctive products that provide solutions to the growing clinical testing sector.
 
WHEATON’S CryoElite Tissue Vials are designed for the safe, secure and effective cryopreservation of biological tissue specimens, which are essential for advances in biomedical research and have demanding requirements for cryogenic storage. They provide researchers a uniform vial able to maintain sample integrity while maximizing storage capacity and organization. CryoElite Tissue Vials were developed with input from industry thought leaders for the high performance tissue banking requirements of anatomical pathology departments, clinical trial organizations and biorepository and biobanking facilities. They offer researchers and clinicians who work with biological specimens ease of use, convenience and security for their precious samples.
 
MicroLiter Chromatography Vials are the industry’s most versatile and innovative, designed for high precision, trouble-free operation for both GC and HPLC applications. All MircroLiter Vials are Class 10,000 clean room packed, making them the clear choice for challenging clinical LOD and LOQ assays and limited quantity specimens and unknown targets.   A complete range of size and closure types are available, designed to the tightest tolerances to ensure that they exceed all autosampler specifications.  When high throughput applications require the use of glass vials, the MicroLiter MPSS allows for robotic liquid handling with the patented “uLmat” that eliminates leakage and cross contamination between wells.
 
Our line of High Recovery Vials has a unique patented interior bottom design, allowing for maximum retrieval of contents and enabling more tests to be conducted from a single vial, providing greater resource efficiency for in vitro diagnostics and diagnostic kits. They are designed for manual or automated handling and storage, and are especially useful for high value reagents and samples, reducing product waste by 99% and enabling full product retrieval without the need to overfill.
 
“We are investing substantial resources to better understand the specific needs of the clinical lab customer and create product solutions addressing those needs, by incorporating innovative, value-added features that help them do their jobs more effectively and efficiently,” said Wayne L. Brinster, CEO and President of WHEATON. “Our CryoElite Tissue Vials provide crucial performance advantages to the rapidly growing tissue banking field; our High Recovery Vials offer much-needed efficiencies to users of high value reagents; and our high precision, versatile, easy to use MicroLiter Chromatography Vials and other WHEATON specialty products show how our 125-year commitment to ongoing innovation and excellence help bring the benefits of scientific advances to our customers and all those they serve.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Mending Tissue - Cellular Instructions for Tissue Repair
NUS-led collaborative study identifies universal mechanism that explains how tissue shape regulates physiological processes such as wound healing and embryo development.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
iPS Cells Discover Drug Target for Muscle Disease
Researchers have designed a model that reprograms fibroblasts to the early stages of their differentiation into intact muscle cells in a step towards a therapeutic for Duchenne muscular dystrophy.
Engineered Hot Fat Implants Reduce Weight Gain
Scientists at UC Berkeley have developed a novel way to engineer the growth and expansion of energy-burning “good” fat, and then found that this fat helped reduce weight gain and lower blood glucose levels in mice.
Transplanted Stem Cells Can Benefit Retinal Disease Sufferers
Tests on animal models show that MSCs secrete growth factors that suppress causes of diabetic retinopathy and macular degeneration.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
Early Detection of Lung Cancer
The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.
Researchers Identify Drug Candidate for Skin, Hair Regeneration
Formerly undiscovered role of protein may lead to the development of new medications that stimulate hair and skin regeneration in trauma or burn victims.
Basis for New Treatment Options for a Fatal Leukemia in Children Revealed
Detailed molecular analyses allow new insights into the function of tumour cells and options for new treatments.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!